Replies to post #130332 on Biotech Values

[DewDiligence]

…doesn't appear to make the claim of having a bulletproof resistance profile.

It would be inappropriate to make such a claim (although many small biotech companies such as EXEL would probably seize the opportunity to do so).

The salient point here is that the resistance DEB025 might induce will be resistance from variants of host proteins, which mutate much more slowly than viral proteins.